Tag: United States

revolutionary-biotech-battle-mpact-on-transplants-in-mantle-cell-lymphoma

Revolutionary Biotech Battle: Impact on Transplants in Mantle Cell Lymphoma

Revolutionary Biotech Battle: Impact on Transplants in Mantle Cell LymphomaIn a groundbreaking showdown at the ASH 2024 conference, the biotech world witnessed an intense rivalry between Arcellx and Legend Biotech over their anti-BCMA CAR-T...
sanofi-faces-federal-threats-over-payment-terms-change-for-drug-discount-program

Sanofi Faces Federal Threats Over Payment Terms Change for Drug Discount Program

Sanofi Faces Federal Threats Over Payment Terms Change for Drug Discount ProgramA recent warning from a U.S. government agency has put pharmaceutical giant Sanofi in hot water over its decision to alter payment terms...
zepbound-eli-lillys-obesity-drug-approved-for-sleep-apnea-treatment-in-us

Zepbound: Eli Lilly’s Obesity Drug Approved for Sleep Apnea Treatment in U.S.

Zepbound: Eli Lilly's Obesity Drug Approved for Sleep Apnea Treatment in U.S.The Food and Drug Administration made a groundbreaking announcement on Friday, granting approval to Eli Lilly's obesity drug, Zepbound, for the treatment of...
news-28112024-060221

Building Resilient Healthcare: Vanessa Kerry’s Climate Change Mission

Vanessa Kerry, a physician specializing in pulmonary and critical care, established Seed Global Health over a decade ago to address disparities in healthcare systems worldwide, particularly in countries with limited resources. In a recent...
fda-approval-onis-rare-disease-therapy-lowers-triglycerides

FDA Approval: Ionis Rare Disease Therapy Lowers Triglycerides

Ionis Pharmaceuticals has achieved a significant milestone by obtaining FDA approval for their groundbreaking therapy, Tryngolza, designed to combat a rare and fatal genetic disease. This therapy targets patients suffering from familial chylomicronemia syndrome...
high-dose-wegovy-trial-shows-significant-weight-loss-but-misses-zepbound-mark

High-Dose Wegovy Trial Shows Significant Weight Loss, But Misses Zepbound Mark

High-Dose Wegovy Trial Unveils Promising ResultsIn a groundbreaking clinical trial conducted by Novo Nordisk, a high dose of their obesity drug Wegovy showed significant potential for weight loss among patients with obesity. Despite this...
nsurance-profits-and-denials-blamed-for-uhc-ceo-death-poll-reveals

Insurance Profits and Denials Blamed for UHC CEO Death, Poll Reveals

UnitedHealthcare CEO Brian Thompson's tragic death on December 4th has sparked a nationwide conversation about the complex web of factors that may have played a role in the shooting. A recent poll conducted by...
reversal-of-bidens-health-care-and-discrimination-protections-by-trump-analysis-and-mplications

Reversal of Biden’s Health Care and Discrimination Protections by Trump: Analysis and Implications

Trump's Reversals of Biden's Health Care and Discrimination Protections: What You Need to KnowIn a bold move that sent shockwaves through the nation, President Trump kicked off his second term by signing an order...
news-29112024-123515

Promoting Evidence-Based Content: YouTube Health’s Fight Against Misinformation

Garth Graham, the global head of healthcare and public health at YouTube, believes that the platform plays a crucial role in providing valuable information to people worldwide. He emphasized the importance of responsibility in...
bidens-medicare-advantage-regulation-boosts-payments-to-nsurers

Biden’s Medicare Advantage Regulation Boosts Payments to Insurers

Biden's Medicare Advantage Regulation Boosts Payments to InsurersIn a groundbreaking move that could reshape the landscape of the Medicare Advantage industry, President Biden's Centers for Medicare and Medicaid Services recently unveiled a...
effective-ways-to-prevent-diabetes-and-mprove-health

Effective Ways to Prevent Diabetes and Improve Health

Effective Ways to Prevent Diabetes and Improve HealthDiabetes is a prevalent disorder in the U.S., affecting about 1 in 9 Americans. The condition raises the risk for severe health issues like eye, kidney, nerve,...
news-11112024-034923

FDA Plans to Ban Cold Medicine, Eisai’s Alzheimer’s Drug Sales, and More: Pharmalittle Update

As we approach the end of another workweek, it's time to start thinking about weekend plans. Our schedule includes tending to the Pharmalot grounds, spending time with our beloved mascots, and catching up on...